Genpact Current Deferred Revenue vs Total Liab Analysis

G Stock

USD 46.50 0.59 1.29%

Genpact financial indicator trend analysis is much more than just examining Genpact Limited latest accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Genpact Limited is a good investment. Please check the relationship between Genpact Current Deferred Revenue and its Total Liab accounts. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Genpact Limited. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price.

Current Deferred Revenue vs Total Liab

Current Deferred Revenue vs Total Liab Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Genpact Limited Current Deferred Revenue account and Total Liab. At this time, the significance of the direction appears to have almost identical trend.

The correlation between Genpact's Current Deferred Revenue and Total Liab is 0.92. Overlapping area represents the amount of variation of Current Deferred Revenue that can explain the historical movement of Total Liab in the same time period over historical financial statements of Genpact Limited, assuming nothing else is changed. The correlation between historical values of Genpact's Current Deferred Revenue and Total Liab is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Current Deferred Revenue of Genpact Limited are associated (or correlated) with its Total Liab. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Total Liab has no effect on the direction of Current Deferred Revenue i.e., Genpact's Current Deferred Revenue and Total Liab go up and down completely randomly.

Correlation Coefficient

0.92

Relationship Direction	Positive
Relationship Strength	Very Strong

View All Relationships

Current Deferred Revenue

Revenue that has been collected but not yet earned, typically from prepaid service contracts or subscriptions. This amount is considered a liability until the service is provided or the subscription period ends.

Total Liab

The total amount of all liabilities that a company has, including both short-term and long-term liabilities.

Most indicators from Genpact's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Genpact Limited current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Genpact Limited. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price.

At this time, Genpact's Enterprise Value Over EBITDA is most likely to slightly decrease in the upcoming years. The Genpact's current Enterprise Value Multiple is estimated to increase to 9.94, while Issuance Of Capital Stock is projected to decrease to roughly 32.4 M.

	2023	2024	2025	2026 (projected)
Gross Profit	1.6B	1.7B	1.9B	2.0B
Total Revenue	4.5B	4.8B	5.5B	5.8B

Gross Profit Total Revenue

Genpact fundamental ratios Correlations

	Total Assets	Total Stockholder Equity	Net Debt	Retained Earnings	Cash	Other Assets	Cash And Short Term Investments	Common Stock Shares Outstanding	Other Stockholder Equity	Total Liab	Total Current Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Other Liab	Property Plant And Equipment Net	Current Deferred Revenue	Accounts Payable	Non Current Assets Total	Non Currrent Assets Other	Long Term Debt	Net Receivables	Good Will	Common Stock Total Equity	Non Current Liabilities Total	Inventory
Total Assets		0.94	0.84	0.68	0.87	0.49	0.87	0.29	0.95	0.97	0.98	0.92	0.98	0.92	0.65	0.84	0.88	0.56	0.97	0.92	0.89	0.81	0.99	-0.68	0.93	-0.18
Total Stockholder Equity	0.94		0.64	0.79	0.82	0.3	0.84	0.35	0.96	0.85	0.97	0.74	0.96	0.82	0.67	0.7	0.72	0.61	0.88	0.78	0.72	0.83	0.91	-0.68	0.78	-0.32
Net Debt	0.84	0.64		0.39	0.6	0.65	0.6	0.0	0.69	0.93	0.73	0.97	0.79	0.85	0.34	0.88	0.83	0.39	0.91	0.93	0.91	0.63	0.89	-0.44	0.92	-0.04
Retained Earnings	0.68	0.79	0.39		0.54	0.19	0.58	0.13	0.69	0.56	0.69	0.48	0.71	0.57	0.43	0.55	0.5	0.76	0.67	0.56	0.45	0.93	0.66	-0.36	0.53	-0.62
Cash	0.87	0.82	0.6	0.54		0.44	1.0	0.48	0.85	0.84	0.9	0.77	0.84	0.78	0.81	0.67	0.86	0.38	0.79	0.77	0.74	0.62	0.82	-0.71	0.79	-0.01
Other Assets	0.49	0.3	0.65	0.19	0.44		0.45	-0.16	0.29	0.6	0.38	0.67	0.45	0.47	0.2	0.68	0.62	0.09	0.59	0.67	0.65	0.3	0.52	-0.08	0.66	0.01
Cash And Short Term Investments	0.87	0.84	0.6	0.58	1.0	0.45		0.47	0.86	0.84	0.91	0.77	0.85	0.78	0.81	0.68	0.86	0.41	0.79	0.77	0.74	0.65	0.82	-0.71	0.79	-0.03
Common Stock Shares Outstanding	0.29	0.35	0.0	0.13	0.48	-0.16	0.47		0.5	0.22	0.4	0.1	0.29	0.17	0.74	0.01	0.17	0.12	0.1	0.05	0.15	0.19	0.18	-0.86	0.16	0.45
Other Stockholder Equity	0.95	0.96	0.69	0.69	0.85	0.29	0.86	0.5		0.88	0.98	0.79	0.96	0.84	0.7	0.66	0.78	0.59	0.86	0.8	0.79	0.81	0.91	-0.82	0.82	-0.12
Total Liab	0.97	0.85	0.93	0.56	0.84	0.6	0.84	0.22	0.88		0.92	0.98	0.94	0.93	0.59	0.88	0.92	0.49	0.97	0.96	0.94	0.75	0.98	-0.63	0.97	-0.08
Total Current Assets	0.98	0.97	0.73	0.69	0.9	0.38	0.91	0.4	0.98	0.92		0.83	0.98	0.86	0.7	0.73	0.83	0.57	0.91	0.84	0.84	0.8	0.95	-0.74	0.87	-0.14
Short Long Term Debt Total	0.92	0.74	0.97	0.48	0.77	0.67	0.77	0.1	0.79	0.98	0.83		0.87	0.91	0.49	0.91	0.92	0.42	0.96	0.97	0.94	0.69	0.94	-0.53	0.96	-0.06
Other Current Liab	0.98	0.96	0.79	0.71	0.84	0.45	0.85	0.29	0.96	0.94	0.98	0.87		0.86	0.61	0.77	0.84	0.59	0.95	0.88	0.88	0.84	0.97	-0.67	0.91	-0.18
Total Current Liabilities	0.92	0.82	0.85	0.57	0.78	0.47	0.78	0.17	0.84	0.93	0.86	0.91	0.86		0.54	0.78	0.86	0.51	0.93	0.94	0.77	0.72	0.94	-0.6	0.81	-0.22
Other Liab	0.65	0.67	0.34	0.43	0.81	0.2	0.81	0.74	0.7	0.59	0.7	0.49	0.61	0.54		0.47	0.57	0.36	0.53	0.46	0.45	0.43	0.56	-0.79	0.53	0.13
Property Plant And Equipment Net	0.84	0.7	0.88	0.55	0.67	0.68	0.68	0.01	0.66	0.88	0.73	0.91	0.77	0.78	0.47		0.82	0.34	0.91	0.88	0.82	0.65	0.84	-0.37	0.9	-0.23
Current Deferred Revenue	0.88	0.72	0.83	0.5	0.86	0.62	0.86	0.17	0.78	0.92	0.83	0.92	0.84	0.86	0.57	0.82		0.37	0.88	0.93	0.87	0.66	0.88	-0.53	0.9	-0.09
Accounts Payable	0.56	0.61	0.39	0.76	0.38	0.09	0.41	0.12	0.59	0.49	0.57	0.42	0.59	0.51	0.36	0.34	0.37		0.54	0.49	0.43	0.79	0.58	-0.36	0.45	-0.49
Non Current Assets Total	0.97	0.88	0.91	0.67	0.79	0.59	0.79	0.1	0.86	0.97	0.91	0.96	0.95	0.93	0.53	0.91	0.88	0.54		0.96	0.89	0.8	0.99	-0.53	0.94	-0.27
Non Currrent Assets Other	0.92	0.78	0.93	0.56	0.77	0.67	0.77	0.05	0.8	0.96	0.84	0.97	0.88	0.94	0.46	0.88	0.93	0.49	0.96		0.89	0.73	0.95	-0.49	0.92	-0.23
Long Term Debt	0.89	0.72	0.91	0.45	0.74	0.65	0.74	0.15	0.79	0.94	0.84	0.94	0.88	0.77	0.45	0.82	0.87	0.43	0.89	0.89		0.69	0.9	-0.54	0.98	0.05
Net Receivables	0.81	0.83	0.63	0.93	0.62	0.3	0.65	0.19	0.81	0.75	0.8	0.69	0.84	0.72	0.43	0.65	0.66	0.79	0.8	0.73	0.69		0.81	-0.52	0.72	-0.42
Good Will	0.99	0.91	0.89	0.66	0.82	0.52	0.82	0.18	0.91	0.98	0.95	0.94	0.97	0.94	0.56	0.84	0.88	0.58	0.99	0.95	0.9	0.81		-0.61	0.93	-0.22
Common Stock Total Equity	-0.68	-0.68	-0.44	-0.36	-0.71	-0.08	-0.71	-0.86	-0.82	-0.63	-0.74	-0.53	-0.67	-0.6	-0.79	-0.37	-0.53	-0.36	-0.53	-0.49	-0.54	-0.52	-0.61		-0.54	-0.27
Non Current Liabilities Total	0.93	0.78	0.92	0.53	0.79	0.66	0.79	0.16	0.82	0.97	0.87	0.96	0.91	0.81	0.53	0.9	0.9	0.45	0.94	0.92	0.98	0.72	0.93	-0.54		-0.04
Inventory	-0.18	-0.32	-0.04	-0.62	-0.01	0.01	-0.03	0.45	-0.12	-0.08	-0.14	-0.06	-0.18	-0.22	0.13	-0.23	-0.09	-0.49	-0.27	-0.23	0.05	-0.42	-0.22	-0.27	-0.04

Click cells to compare fundamentals

Genpact Account Relationship Matchups

Genpact fundamental ratios Accounts

	2021	2022	2023	2024	2025	2026 (projected)
Total Assets	5.0B	4.6B	4.8B	5.0B	5.7B	3.2B
Total Stockholder Equity	1.9B	1.8B	2.2B	2.4B	2.7B	1.5B
Net Debt	1.1B	1.1B	919.3M	796.8M	916.4M	481.1M
Retained Earnings	732.5M	780.0M	1.1B	1.2B	1.4B	1.5B
Cash	899.5M	646.8M	583.7M	648.2M	745.5M	462.1M
Other Assets	667.3M	439.6M	1.0	461.1M	530.3M	318.8M
Cash And Short Term Investments	899.5M	646.8M	583.7M	671.6M	772.3M	485.3M
Common Stock Shares Outstanding	193.0M	188.1M	185.1M	180.4M	207.5M	205.2M
Liabilities And Stockholders Equity	5.0B	4.6B	4.8B	5.0B	5.7B	3.2B
Other Stockholder Equity	1.7B	1.8B	1.9B	1.9B	2.2B	1.4B
Total Liab	3.1B	2.8B	2.6B	2.6B	3.0B	1.7B
Total Current Assets	1.9B	1.8B	1.9B	2.1B	2.4B	1.3B
Short Long Term Debt Total	2.0B	1.7B	1.5B	1.4B	1.7B	990.3M
Other Current Liab	612.3M	614.8M	635.9M	698.7M	803.6M	476.0M
Total Current Liabilities	1.3B	1.1B	1.3B	963.7M	1.1B	773.6M
Other Liab	192.2M	239.9M	249.2M	208.0M	239.2M	192.5M
Property Plant And Equipment Net	520.0M	405.5M	393.7M	409.0M	470.3M	301.7M
Current Deferred Revenue	160.6M	160.6M	112.4M	105.7M	121.5M	79.8M
Accounts Payable	25.0M	35.8M	27.7M	36.5M	41.9M	44.0M
Non Current Assets Total	3.1B	2.8B	2.9B	2.9B	3.3B	2.0B
Non Currrent Assets Other	526.7M	494.4M	384.0M	387.8M	446.0M	256.7M
Long Term Debt	1.3B	1.2B	824.7M	1.2B	1.4B	721.4M
Net Receivables	896.2M	1.0B	1.1B	1.2B	1.4B	1.5B
Good Will	1.7B	1.7B	1.7B	1.7B	1.9B	1.2B
Common Stock Total Equity	1.9M	1.9M	1.8M	1.8M	1.6M	2.6M
Non Current Liabilities Total	1.8B	1.7B	1.2B	1.6B	1.9B	1.0B
Inventory	150.1M	103.7M	1.0	9.5M	10.9M	10.4M
Other Current Assets	125.9M	126.4M	174.1M	177.3M	203.9M	178.6M
Property Plant And Equipment Gross	485.7M	379.1M	984.1M	988.5M	1.1B	1.2B
Accumulated Other Comprehensive Income	(554.4M)	(733.1M)	(722.6M)	(794.1M)	(714.7M)	(678.9M)
Short Term Debt	463.6M	246.8M	503.4M	87.4M	100.5M	187.9M
Intangible Assets	169.6M	89.7M	53.0M	27.0M	31.0M	29.4M
Common Stock	1.8M	1.8M	1.8M	1.7M	1.6M	2.4M
Property Plant Equipment	485.7M	379.1M	431.8M	409.0M	470.3M	260.9M
Short Term Investments	5.8M	5.4M	4.4M	23.4M	21.0M	29.7M
Net Tangible Assets	(116.2M)	(98.2M)	(3.5M)	52.2M	47.0M	44.7M

Currently Active Assets on Macroaxis

JBL	Jabil Circuit
MRK	Merck Company
AMGN	Amgen Inc
WMT	Walmart Common Stock
QYLD	Global X NASDAQ

How To Invest In Genpact

Details

Is Genpact Stock a good investment?

Details

What is Genpact's Net Worth?

Details

Largest Data Processing & Outsourced Services Companies

View

Largest Commercial & Professional Services Companies

View

Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Genpact Limited. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price.

You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.

Is Data Processing & Outsourced Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Genpact. If investors know Genpact will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Genpact listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

0.122

Dividend Share

0.663

Earnings Share

3.1

Revenue Per Share

28.641

Quarterly Revenue Growth

0.066

The market value of Genpact Limited is measured differently than its book value, which is the value of Genpact that is recorded on the company's balance sheet. Investors also form their own opinion of Genpact's value that differs from its market value or its book value, called intrinsic value, which is Genpact's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Genpact's market value can be influenced by many factors that don't directly affect Genpact's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Genpact's value and its price as these two are different measures arrived at by different means. Investors typically determine if Genpact is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Genpact's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2026 Macroaxis LLC

Genpact Current Deferred Revenue vs Total Liab Analysis

Current Deferred Revenue vs Total Liab

Current Deferred Revenue vs Total Liab Correlation Analysis

Correlation Coefficient

Current Deferred Revenue

Total Liab

Genpact fundamental ratios Correlations

Genpact Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Genpact fundamental ratios Accounts

Currently Active Assets on Macroaxis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Cash And Short Term Investments	+ 1.0	Cash
Good Will	+ 0.99	Total Assets
Good Will	+ 0.99	Non Current Assets Total
Total Current Assets	+ 0.98	Total Assets
Other Current Liab	+ 0.98	Total Assets
Total Current Assets	+ 0.98	Other Stockholder Equity

Common Stock Total Equity	- 0.86	Common Stock Shares Outstanding
Common Stock Total Equity	- 0.82	Other Stockholder Equity
Common Stock Total Equity	- 0.79	Other Liab
Common Stock Total Equity	- 0.74	Total Current Assets
Common Stock Total Equity	- 0.71	Cash And Short Term Investments
Common Stock Total Equity	- 0.71	Cash